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Abstract
Background: In genome-wide association studies (GWAS), the number of single-nucleotide polymorphisms (SNPs)
typically ranges between 500,000 and 1,000,000. Accordingly, detecting gene-gene interactions in GWAS is
computationally challenging because it involves hundreds of billions of SNP pairs. Stage-wise strategies are often
used to overcome the computational difficulty. In the first stage, fast screening methods (e.g. Tuning ReliefF) are
applied to reduce the whole SNP set to a small subset. In the second stage, sophisticated modeling methods (e.g.,
multifactor-dimensionality reduction (MDR)) are applied to the subset of SNPs to identify interesting interaction
models and the corresponding interaction patterns. In the third stage, the significance of the identified interaction
patterns is evaluated by hypothesis testing.
Results: In this paper, we show that this stage-wise strategy could be problematic in controlling the false positive
rate if the null distribution is not appropriately chosen. This is because screening and modeling may change the
null distribution used in hypothesis testing. In our simulation study, we use some popular screening methods and
the popular modeling method MDR as examples to show the effect of the inappropriate choice of null
distributions. To choose appropriate null distributions, we suggest to use the permutation test or testing on the
independent data set. We demonstrate their performance using synthetic data and a real genome wide data set
from an Aged-related Macular Degeneration (AMD) study.
Conclusions: The permutation test or testing on the independent data set can help choosing appropriate null
distributions in hypothesis testing, which provides more reliable results in practice.
Background
Single-nucleotide polymorphisms (SNPs) serve as mar-
kers for mapping disease-associated genetic variants. It
has been well known that SNP profiles are associated
with a variety of diseases [1]. High-throughput genotyp-
ing technologies have been used to assay hundreds of
thousands of SNPs in the human genome. Many single-
locus based methods [2] have been proposed and many
susceptibility determinants have been identified [1].
However, these identified SNPs seem to be insufficient
in explaining the genetic contributions to complex dis-
eases [3]. Researchers start to suspect that the causality
of many common disease are more related with gene-
gene interactions rather than with single genetic varia-
tions [3,4]. For many common complex diseases, some
SNPs have shown little main effects while their interac-
tions are significantly associated with disease traits [5-7].
Consequently, detecting gene-gene interactions is a
topic of current interest in GWAS [4]. Many methods
have recently been proposed to identify interaction pat-
terns associated with diseases, including MDR [6], CPM
[5], RPM [8], BGTA [9], SNPRuler [10], LASSO [11-13],
HapForest [14], BOOST [15], PLINK [16], BEAM [17],
SNPHarvester [18] and INTERSNP [19]. However, a key
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computational burden [4]. For example, to find pairwise
interactions from 500,000 SNPs, we need 1.25 × 10
11
statistical tests in total. To address this issue, screening
approaches [20] have been proposed. The whole process
of detecting gene-gene interactions is then divided into
three stages:
￿ Screening: Evaluate the importance of each SNP and
assign it a score. Those SNPs with scores lower than the
given threshold are removed without further considera-
tion. Often a small portion of SNPs remains. This stage
is often accomplished by fast algorithms using heuristics
to reduce the search space of the next stage. One exam-
ple is the popular screening method Tuning ReliefF [21].
￿ Modeling: Search for the best combination of SNPs
in the remaining SNPs. The exhaustive search can be
used in this stage because the number of remaining
SNPs is small, e.g., the popular modeling methods MDR
and CPM. During the search process, the importance of
a SNP combination is often measured by its prediction
accuracy (typically evaluated by cross-validation). Thus,
the best SNP combination and its corresponding inter-
action pattern can be identified in term of prediction
accuracy.
￿ Testing: Assess the significance of interaction pat-
terns by hypothesis testing.
Hypothesis testing employed in the testing stage is
also referred to as “feature assessment” in [22]. A critical
issue in feature assessment is to choose an appropriate
null distribution for hypothesis testing. An inappropriate
null distribution may lead to an over-optimistic result
(high false positive error) or an over-conservative result
(high false negative error) [23]. Figure 1 gives a toy
example. In this figure, null distribution 1 follows the χ2
distribution with the degree of freedom df =4 ,d e n o t e d
as df =4
2
, and null distribution 2 follows df =8
2
.I ft h e
true null distribution is df =8
2
,t h e nu s i n g df =4
2
for
hypothesis testing will give many false positive results.
In this paper, we show through simulations that both
screening and modeling may change the null distribution
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Figure 1 A toy example illustrating the effect of the inappropriate choice of null distributions. Null distribution 1 follows the df =4
2
and null distribution 2 follows the df =8
2
. The observed χ2 value is 10, and the P-values are 0.0404 and 0.2650 for these two null distributions,
respectively. Suppose P = 0.05 is the threshold of hypothesis testing. Then P = 0.0404 indicates a significant result, while P = 0.2650 does not. If
the true null distribution is df =8
2
, then the use of df =4
2
will give many false positive results.
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(such as MDR combined with Tuning ReliefF [6,21] and
some other stage-wise methods [24]) neglect the right-
ward shift of the original null distribution (as illustrated
in Figure 1) caused by screening and modeling. They
inevitably suffer from the higher false positive rate. We
have also noticed that some methods [25-27] modify the
test statistics, which causes the leftward shift of the origi-
nal null distribution. If we still stick to the theoretical
null distribution in hypothesis testing, we may produce
conservative results (see the discussion section). To
address this issue, we suggest to use the permutation test
and testing on the independent data set. The permuta-
tion test uses the re-sampling method to estimate the
changed null distribution for hypothesis testing. Testing
on the independent data set can reserve the theoretical
null distribution. Through simulation experiments and
the experiment on a real genome-wide data set from an
AMD study, we demonstrate that the appropriate choice
of null distributions leads to more reliable results.
Results
Simulation study of the inappropriate choice of null
distributions
The huge number of SNPs in GWAS poses a heavy
computational burden for detecting gene-gene interac-
tions. The exhaustive search of all pairwise interactions
and further using cross-validation to evaluate them (e.g.
MDR [6]) become impractical in GWAS. To make it
computationally feasible, a screening method is applied
to the whole data set to pre-select a small subset of
SNPs. Then the exhaustive search can be applied to
identify the most likely disease-associated SNPs. At last,
hypothesis testing is conducted on identified SNPs. The
importance of hypothesis testing is briefly discussed in
the discussion section. Here we use MDR and some effi-
cient screening methods [21,28-30] as examples to show
that null distributions are affected by these methods
Throughout this paper, we use the latest MDR software
(MDR 2.0 beta 8.1) to perform all experiments. It also
implements various screening methods, such as ReliefF,
Tuning ReliefF, and SURFSTAR. We first show that the
modeling process of MDR changes the null distribution
in its search process. Then we show that MDR coupled
with some screening methods further changes the null
distribution.
The null distribution of MDR
MDR is a popular non-parametric approach for detect-
ing all possible k-way (k =2 , …, d) combinations of
SNPs that interact to influence disease traits. MDR runs
10-fold cross-validations, and uses the prediction errors
and the consistencies to search for the optimal set of
k-way interactions. For each of the selected k-way inter-
actions, MDR constructs a 2 × 2 contingency table by
partitioning the samples into the high-risk and low-risk
groups. Then MDR conducts hypothesis testing based
on this 2 × 2 contingency table. Table 1 illustrates how
this is done by MDR. The authors claimed that MDR
could reduce the k dimensional model into a 1 dimen-
sional model [6]. Therefore, the current MDR software
conducts the statistical test on a 2 × 2 contingency table
using df =1
2
as its null distribution. This statement is
biased because the higher dimensional space has to be
browsed in order to construct the 2 × 2 continency
table [31]. Here we use simulation experiments to show
the correct null distribution in hypothesis testing for
MDR.
We design two scenarios with three settings of d-way
interactions (d = 2, 3, 4), one showing the true null dis-
tributions of MDR (without search) and another show-
ing the change of null distributions of MDR (with
search). For each scenario of this experiment, we gener-
ate 500 null data sets, each of which contains 2,000
samples.
In the first scenario, we generate data sets containing
two, three and four SNPs for the settings d =2 ,3 ,4 ,
respectively. All SNPs are generated using the Hardy-
Weinberg principle with minor allele frequencies uni-
formly distributed in [0.05,0.5]. By doing so, the MDR
model can be directly fitted without search. Let us take d
= 2 as an example. For each null data set, we first obtain
a genotype contingency table as shown in Table 1, and
then collapse it into a 2 × 2 contingency table. Next we
conduct the statistical test (either the Pearson χ2 test or
the likelihood ratio test can be used since their difference
is ignorable). The histogram of the statistics forms the
null distribution. For d = 3,4, this can be done in the
same way. The histograms of these null distributions
obtained from 500 null data sets are shown in the upper
Table 1 A toy example illustrating how MDR collapses
two 3 × 3 genotype tables to a 2 × 2 contingency table
Case BB Bb bb Control BB Bb bb MDR
table
Case Control
AA 179 119 18 AA 199 126 15
Aa 315 173 26 Aa 306 164 17 Low-
risk
399 443
aa 101 59 10 aa 118 49 6 High-
risk
601 557
Suppose the threshold of the odds ratio in MDR is specified to be τOR =1 .
Then the 2 × 2 contingency table is obtained by MDR in the following way:
For the cells whose odd-ratio is higher than τOR will be considered as high-
risk. For case genotypes, the bold numbers indicate these genotypes are
considered as high-risk. Their summation equals to 601 as shown in bold font
in the MDR table. For control genotypes, the italic numbers also indicate
these genotypes are considered as high-risk. Their summation equals to 557
as shown in italic font in the MDR table. For the low-risk cells, this is done in
the same way. Statistical tests can be conducted based on the 2 × 2
contingency table: χ2 = 3.9711 for the Pearson χ2 test and χ2 = 3.9726 for the
likelihood ratio test.
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of MDR (without search) follow the χ2 distributions. The
estimated degrees of freedom of the χ2 distributions are
df = 4.84, df = 11.40 and df = 30.41 for d =2 ,d = 3 and d
= 4, respectively. The non-interger degree of freedom is
well defined, see [31-33]. This clearly indicates that
df =1
2
is not an appropriate null distribution for MDR.
In the second scenario, we generate the data sets
containing 20 SNPs for all three cases. These SNPs are
g e n e r a t e di nt h es a m ew a ya si nt h ef i r s ts c e n a r i o .I n
this scenario, MDR first searches for the best d*-way
interactions using 10-fold cross-validation and then
conducts the testing. The results are shown in the
lower panel of Figure 2. Compared with the first
scenario, the null distributions change when MDR
searches for the best d*-way interactions (d* = 2, 3,4)
in d = 20 dimensions. We see that the null distribu-
tions do not strictly follow χ2 distributions. We use χ2
distributions to approximate them, and obtain their
degrees of freedom as df = 13.76, df =2 9 . 4 9a n ddf =
64.64, respectively.
In summary, our result shows the following facts:
￿ The null distribution in MDR does not follow df =1
2
even when search process is not involved.
￿ The null distribution in MDR further changes when
the search process is involved.
Therefore, hypothesis testing using df =1
2
as the null
distribution in MDR will give many false positive results.
0 20 40 60
0
20
40
60
80
100
← χ2
df =4.84
MDR (d=2)
0 20 40 60
0
20
40
60
80
100
← χ2
df =11.40
MDR (d=3)
0 50 100
0
20
40
60
80
100
← χ2
df =30.41
MDR (d=4)
0 20 40 60
0
20
40
60
80
100
← χ2
df =13.76
χ
2 value
MDR (d
*=2)
0 20 40 60
0
20
40
60
80
100
← χ2
df =29.49
χ
2 value
MDR (d*=3)
0 50 100
0
20
40
60
80
100
χ2
df =64.64 →
χ
2 value
MDR (d*=4)
Figure 2 Null distributions affected by MDR modeling. The null distributions are estimated using 500 simulated null data sets. Each null data
set contains n = 2000 samples. Upper panel: From left to right, each data set has L =2 ,L =3 ,L = 4 SNPs. MDR can be applied to these data
sets without model search to fit the two-factor model (d = 2), the three-factor model (d = 3), and the four-factor model (d = 4). The resulting
null distributions follows χ2 distributions with df = 4.84, 11.40, 30.41, respectively. Lower panel: Each null data set contains n = 2000 samples
and L = 20 SNPs. MDR is directly applied to each data set. MDR searches all possible models and cross-validation is used to assess each model.
The best two-factor model (d* = 2), the best three-factor model (d* = 3), and the best four-factor model (d* = 4) are identified. Their
distributions, shown from left to right, do not strictly follow χ2 distributions.
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methods
MDR works well for small studies with 100 or less
SNPs. In GWAS, it is not practical to use this exhaus-
tive search method. Therefore, many screening methods
have been proposed to reduce the number of SNPs
before MDR is applied to detect d*-way interactions.
These screening methods include ReliefF [28,29], Tun-
ing ReliefF (TURF) [21], SURF [34], SURFSTAR [30].
The reader is referred to [20] for a recent review on
these screening methods.
The issue here is that after these screening methods
are applied, the null distributions are further changed.
To show the effect of screening methods on the null
distribution, we generate 500 null data sets. Each data
set contains 2,000 samples and each sample contains
L = 2,000 SNPs. All SNPs are generated using the
Hardy-Weinberg principle with minor allele frequencies
uniformly distributed in [0.05,0.5]. Different screening
methods, such as ReliefF, TURF, SURFSTAR, are first
applied to reduce L = 2,000 SNPs to d = 20 SNPs. After
that, MDR is applied to find the best d*-way interactions
(d* = 2, 3, 4). Figure 3 presents the experiment results.
The lower panel of Figure 2 serves as the reference dis-
tributions. It is obvious that all three screening methods
further change the null distributions.
Simulation study of the suggested solutions
Two solutions are suggested in the method section. The
first one is the permutation test and the second is
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Figure 3 Null distributions affected by screening methods. The null distributions are estimated using 500 simulated null data sets. The null
distributions shown in the lower panel of Figure 2, serve as the reference distributions (df = 13.76 for d*=2 ,df = 29.49 for d* = 3 and df =
64.64 for d* = 4). The screening methods ReliefF, TURF and SURFSTAR are used to reduce the number of SNPs from L = 2000 to d = 20. For the
remaining d = 20 SNPs, MDR is used to identify the best d*-way interactions (d* = 2, 3, 4). The resulting null distributions of these models,
shown from left to right, do not strictly follow the χ2 distribution. The null distributions shift rightwards, compared with those distributions in the
lower panel of Figure 2.
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test works well to estimate null distributions in practice.
Although the computational cost of this method is high,
it is still feasible to be applied in GWAS when an effi-
cient screening method is available. It is unnecessary to
show its performance in simulation studies since it is a
standard way of calibrating the null distribution in
hypothesis testing [35,36]. We demonstrate its perfor-
mance using a real genome-wide data set from an AMD
study in the next section. Here we show that the null
distribution does not change when testing on an inde-
pendent data set. We generate 500 null data sets. Each
data set contains 2,000 samples and each sample has
L = 2,000 SNPs. Each data set is partitioned into three
subsets as nearly equal as possible: D
(1), D
(2), D
(3).T h e
screening method ReliefF is first applied to D
(1), and the
number of SNPs is reduced from L =2 , 0 0 0t od =2 0
SNPs. The indices of the remaining 20 SNPs are col-
lected in A1. After that, stepwise logistic regression (LR)
is applied to D
(2) to find the best d*-way interactions
(d* = 2, 3, 4) among the SNPs in A1. At last, the likeli-
hood ratio test is applied to the identified SNP set in
hypothesis testing: it uses the difference between the
deviance of the full d*-way logistic regression interaction
model and the deviance of the null logistic regression
model. Here we first use LR rather than MDR, because
the null distributions of LR are known analytically. For
2, 3, 4-way full logistic regression interaction models,
the null distributions follow χ2 distributions with df =8 ,
26, 80, respectively. The experiment results are present
in the upper panel of Figure 4. We can see that the
obtained null distributions of logistic regression models
match the theoretical null distributions well for 2,
3-way interaction models. For the 4-way interaction
model, the estimated null distribution has a smaller
degree of freedom than the theoretical null distribution.
This is because about 666 samples are not enough to
accurately estimate the large degree of freedom of the
theoretical null distribution (df =8 0 ) .T h i si sad i s a d -
vantage of using an independent data set for testing.
When there are not enough samples, testing on an
independent data set may have a lower power if its the-
oretical null distribution is used (This is an opposite
case of the one shown in Figure 1).
To see the effect of MDR using the independent data
set in hypothesis testing, we similarly divide each null
data set into three subsets: D
(1), D
(2), D
(3). ReliefF is
applied to D
(1) and then MDR is applied to D
(2). At last,
χ2 tests are conducted on D
(3) u s i n gt h e2×2c o n t i n -
gency tables obtained by the MDR method. The result
is shown in the lower panel of Figure 4. We can see
that the obtained null distributions of MDR agree with
the distributions shown in the upper panel of Figure 2.
This result clearly shows that the null distributions are
not changed by screening and modeling when testing on
the independent data set.
Real data analysis using the suggested solutions: an
experiment on the Aged-related Macular Degeneration
(AMD) data set
We use the AMD data from [37] as a real example. The
AMD study genotyped 116,204 SNPs on 96 cases and
50 controls. After applying quality control to the AMD
data set, we have 82,143 qualified SNPs. Two significant
loci, rs380390 and rs1329428, were reported in [37]
based on the allelic association test with degree of free-
dom df =1 .
First, we use the latest MDR software to analyze this
data set. ReliefF is applied to reduce the number of SNPs
in AMD data from L = 82, 143 to d = 20. After that,
MDR is applied to the remaining 20 SNPs to search for
the best model. The result is given in Table 2. The AMD
data set is available at http://bioinformatics.ust.hk/Null-
DistrAMD.zip. Our analysis result given in Table 2 can
be freely reproduced. Following the typical selection pro-
cedure of MDR, the four-way interaction (i.e., model M4)
among SNPs (rs1535891, rs2828151, rs404569, rs380390)
is considered as the best one. If the effect of screening
and modeling on changing the null distribution is not
taken into account, then the hypothesis testing on M4
using the null distribution df =30 41
2
. (see the upper panel
of Figure 2 (d = 4)) will give a P-value of 4.226 × 10
–7,
which is a significant result.
Second, we use the permutation test to re-examine the
above result. We conducted B = 500 permutations to
the AMD data set. The details are given in the method
section. The result is shown in Figure 5. The P-value
obtained by the permutation test for model M4 is
0.1480, which is far from being significant. More impor-
tantly, the permutation result shows that model M1 is
significant with P-value 0.0040. This result is consistent
with that in the original paper [37].
Third, we apply testing on the independent data set.
The whole data set is partitioned into three groups (49,
49 and 48 individuals, respectively). ReilefF, MDR and
hypothesis testing are sequentially applied to them, as
described in the method section. Finally, no significant
features are reported. This seems different from the
result of the permutation test. The reason is that testing
on the independent data set has a lower power than the
permutation test. The number of samples of the AMD
data set is very small (146 individuals). After a nearly
equal partition of the data set, only 48 samples can be
used in hypothesis testing. Thus no significant results
can be detected (see more explanations in the simula-
tion study section). Since the permutation test often has
a higher power, the permutation test is preferred when
the computational cost is affordable.
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The importance of hypothesis testing in feature
assessment
It is important to note that hypothesis testing plays a
key role in feature assessment [22,23]. Model selection
is a closely related topic, which aims to identify the best
model in term of the prediction accuracy [22]. Analyti-
cal methods such as Akaike information criterion (AIC),
Bayesian information criterion (BIC) can be applied for
model selection. Efficient sample re-use methods such
as cross-validation and bootstrapping can be applied
here as well. However, to statistically quantify the
importance of selected features, feature assessment is
preferred. Instead of considering prediction accuracy,
feature assessment makes use of hypothesis testing to
statistically assess the significance of features. To char-
acterize the performance of hypothesis testing, different
measures have been defined, e.g., the family wise error
rate (FWER) and the false discovery rate (FDR) [35,36].
The Bonferroni correction and the Benjamini-Hochberg
method [38] can be used for controlling FWER and
FDR, respectively.
As pointed out by Efron [23], the choice of null distri-
bution is critical in hypothesis testing. The empirical null
distribution may not match the theoretical null distribu-
tion due to reasons such as inappropriate assumptions or
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Figure 4 Null distributions of testing on the independent data set. We generate 500 null data sets. Each data set has 2000 samples and
2000 SNPs. We divide each data set into three subsets with nearly equal size. The first one is used for screening, the second one is for
modeling and the third one is for hypothesis testing. The upper panel: Logistic regression (LR) is used in modeling. The degrees of freedom of
the theoretical null distributions are df = 8,26,80 for 2,3,4-way interaction models, respectively. We see that the null distributions of LR match the
theoretical null distributions well for 2,3-way interaction models. The resulting null distribution of the 4-way interaction model follows
df =73 18
2
. Here df = 73.18 is smaller than the theoretical one (df = 80) because there are only about 666 samples in hypothesis testing. The
number of samples is too small to accurately estimate the large degree of freedom of the theoretical null distribution (df = 80). The lower
panel: MDR is used in modeling. We can see that the obtained null distributions are roughly the same with those shown in the upper panel of
Figure 2.
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shows that screening (e.g, ReliefF) and modeling (e.g,
MDR) can also change the null distribution. If their effect
is not taken into account in hypothesis testing, the result-
ing feature assessment will be unreliable.
Related work
We have shown that inappropriate choice of null distri-
butions will give misleading results of hypothesis testing.
One example is that MDR combined with Tuning ReliefF
[6,21] will give over-optimistic results. Alternatively,
Table 2 The experiment result on the AMD data set
Model SNP name CV accuracy CV consistency χ2-value
M1 rs1329428 0.7246 10/10 27.1480
M2 rs1329428, rs9299597 0.7086 6/10 38.3007
M3 rs1535891, rs1329428, rs9299597 0.7833 3/10 55.4297
M4 rs1535891, rs2828151, rs404569, rs380390 0.7615 10/10 85.2449
The result obtained by using MDR after screening. ReliefF is used to reduce the number of SNPs from L = 82, 143 to d = 20. After that, MDR is applied to the
remaining 20 SNPs to search for the best model. The fourth-way interaction model M4 is considered as the best model because it gives high CV accuracy and CV
consistency. Here CV stands for cross-validation. The χ2-value of 85.2449 will correspond to a P-value of 4.226 × 10
–7 against the null distribution df =30 41
2
.
(the upper panel of Figure 2 (d = 4)), indicating a significant hypothesis testing result. But the permutation test gives it a P-value of 0.1480 (Figure 5), indicating a
non-significant result.
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Figure 5 Null distributions obtained using the permutation test. We conduct B = 500 permutations for the AMD data set, as described in
the method section. The P-values obtained by the permutation test for models M1, M2, M3, M4 are 0.0040, 0.1180, 0.2880 and 0.1480,
respectively. Only model M1 is significant. The claim of the significance of the high order interaction (rs1535891, rs2828151, rs404569, rs380390)
based on Model M4 in Table 2 is inappropriate.
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tistic but stick to the theoretical null distribution, may
produce conservative results. For example, Machini et. al
[25] proposed a two-stage method for detecting interac-
tions in genome-wide scale. In the first stage, a single-
locus-based test was performed. Those SNPs with
significant P-values (i.e., smaller than a certain threshold
a) were selected. The selected set of SNPs was denoted
as I1 (I1 ⊂ {1,…, L}). In the second stage, for each pair
of SNPs l and m (l, m Î I1,l≠ m), the log likelihood
ratio statistic R(l, m) was calculated for the full interac-
tion model. They defined a new statistic R′(l, m)=R(l,
m) – (kl + km), where kl and km were the single-locus χ2
values for SNPs l and m. The significance of this statis-
tic was assessed against df =8
2
distribution, where df =
8 is the degrees of freedom of the full model fitted at
the two SNPs. They showed that their method was con-
servative in term of the false positive rate. In fact, the
modified statistic R′(l, m)i sas h r u n k e nv e r s i o no fR(l,
m), but hypothesis testing is performed using the degree
of freedom of R(l, m), where l, m Î{1,…, L}, l ≠ m.
Thus, this method will be too conservative to detect
interesting interactions.
Conclusion
GWAS have identified many genomic regions associated
with complex diseases. However, some previously
reported results are based on an inappropriate choice of
null distributions, which will produce many false posi-
tive results. In this work, we have illustrated that both
screening and modeling can change the null distribution
used in hypothesis testing. This causes unreliable signifi-
cance assessment. We have suggested two solutions to
address this issue. One is to use the permutation test
and another is to use the independent data set for test-
ing. Both solutions can help to appropriately choose
null distributions, while the permutation test has a
higher power with more computational cost.
Method
The null distribution is changed after the screening step
and the modeling step in the stage-wise procedure. In
this section, we suggest two solutions to address this
issue. The first solution is to use the permutation test,
which uses the re-sampling to generate the reference
distribution for hypothesis testing. The second one is to
use the independent data set for testing, which reserves
the theoretical null distribution.
Suppose we have L SNPs and n samples for an asso-
ciation study. The whole data set D =[ X; Y]i sa n( L +
1) × n matrix, where we use X to denote all SNPs with
the l-th column Xl corresponding to the l-th SNP, and
use Y to denote the phenotype.
Permutation test
Since the screening step and the modeling step can
change the null distribution, using theoretical null distri-
bution in hypothesis testing may produce biased statis-
tics, which will lead to a high false positive rate. The
permutation test can generate the correct null distribu-
tion which has accounted for the effects of screening
and modeling. This null distribution can be directly
used in hypothesis testing. Specifically, the permutation
test is done in the following steps:
1. Compute the test statistic based on original data.
Apply an efficient screening method to D and reduce it
to D′,w h e r eD′ is a (d +1 )×n matrix collecting the
top d features. Next, apply modeling methods such as
MDR to D′ to identify the best model f(X*), where X*
has d* features. Then calculate the test statistic of model
f(X*) based on all samples, denoted as tobs.
2. Generate B independent vectors Y(1),…, Y(B) by ran-
domly permuting the response variable Y.E v a l u a t et h e
permuted statistic T(b) of the same procedure in Step 1
corresponding to the permuted data set D(b) =[ X; Y(b)],
b =1 , …,B.
3. Calculate the P-value as
1
1 B
IT t jo b s
j
B
() . ()>
= ∑ (1)
where I(·) is the indicator function.
In theory, a larger number of permutations will pro-
duce more accurate estimation. In practice, we typically
use between 200 and 1000 permutations due to the high
computational cost in the permutation test.
Testing on the independent data set
Screening and modeling pre-use the data that will be
used in hypothesis testing. This leads to the change of
the null distribution. Using an independent data set in
hypothesis testing will avoid the change of the null dis-
tribution. It is particularly useful for those methods hav-
ing analytic null distributions, for example, the
likelihood ratio test for logistic regression models. This
method consists of the following steps and it is also illu-
strated in Figure 6.
1. Partition the whole data set D into three subsets
with nearly equal size: D
(1), D
(2) and D
(3).
2. Apply an efficient screening method to D
(1) and
identify a subset of features, denoted as A1.L e t| A1|
denote the size of A1 and we have |A1| ⊈ L.
3. Apply a modeling method to D
(2) by only involving
the features in A1. The identified features are collected
in A2 and we have A2 ⊂ A1.
4. Perform hypothesis test on the features in A2 using
t h ed a t as e tD
(3). The correction factor for multiple
Yang et al. BMC Bioinformatics 2011, 12(Suppl 1):S26
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Page 9 of 11testing can be calculated based on |A2|. The detected
significant features are collected in A3 and A3 ⊂ A2.
These features are finally used for genetic mapping.
This solution can be applied without sacrificing the
running time. However, it has a requirement on the
number of samples. A small sample size will degrade its
performance. In that situation, the permutation test is a
better choice.
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